A review of ketamine’s role in ECT and non-ECT settings
Vytautas Jankauskas,1 Candace Necyk,2 James Chue,3 Pierre Chue4 1Department of Pharmacy, Grey Nuns Community Hospital, Edmonton, Alberta, Canada; 2Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada; 3Department of Anesthesiology, State University of Ne...
Guardado en:
Autores principales: | Jankauskas V, Necyk C, Chue J, Chue P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fef3a95d03fa475a9a3bb5bb8c34b25b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ventilation Adjustment in ECT During COVID-19: Voluntary Hyperventilation is an Effective Strategy
por: de Arriba-Arnau A, et al.
Publicado: (2021) -
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach J, et al.
Publicado: (2020) -
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Wei Zheng, et al.
Publicado: (2021) -
Number of Electroconvulsive Therapy Sessions required for Thai Psychiatric Patients: a Retrospective Study
por: Ittasakul P, et al.
Publicado: (2020) -
Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT
por: Aksay SS, et al.
Publicado: (2014)